Omron Q1 FY2027: Operating Profit Surges 226%, Full-Year Outlook Raised

Omron got off to an exceptionally strong start in FY2027, with all segments posting revenue growth and operating profit more than tripling. Consolidated revenue reached ¥209.9 billion (+26.1% year on year), while operating profit soared 226.0% to ¥18.9 billion. The operating margin improved sharply to 9.0% from 3.5% a year earlier.

The dramatic recovery was driven primarily by the core Industrial Automation Business (IAB), which secured orders tied to AI-related investments in semiconductors and secondary batteries for data centers. Strengthened distributor relationships and new product launches also helped expand the customer base. IAB revenue surged 37.2% to ¥131.2 billion, accounting for over 60% of total sales. The Healthcare Business (HCB) also performed well, with revenue up 16.7% on strong online sales of blood pressure monitors in Japan and Asia, while the Data Solutions Business (DSB) remained solid.

Foreign exchange provided a significant tailwind: the average rate was ¥159.6 to the dollar (vs. ¥145.7 a year earlier) and ¥185.3 to the euro (vs. ¥162.9). The results handily beat the company�s initial assumptions and prompted an upward revision to the full-year forecast.

Industrial Automation Business (IAB): External sales rose 37.2% year on year to ¥131.2 billion, while operating profit doubled to ¥21.3 billion (+100.8%). Worldwide capital expenditure on semiconductor manufacturing equipment and data centers boosted demand for mainstay products such as programmable controllers and sensors. AI-driven demand was the key earnings driver, significantly enhancing profitability.

Healthcare Business (HCB): Sales increased 16.7% to ¥36.4 billion, and operating profit jumped 101.7% to ¥2.4 billion. Blood pressure monitors performed strongly, especially in Japan and Asia, where online sales initiatives paid off. Rising health awareness in emerging markets such as China and India also provided a tailwind.

Social Systems Solutions & Service Business (SSB): Sales edged down 2.0% to ¥24.2 billion, while operating profit shrank 62.5% to just ¥0.1 billion. Residential storage battery systems were sluggish, although railway and management service operations held firm. Competitive pressure in this segment intensified.

Data Solutions Business (DSB): Sales grew 22.8% to ¥13.1 billion, and the segment swung to an operating profit of ¥0.3 billion (vs. a ¥0.1 billion loss a year earlier). Data healthcare and corporate health services remained buoyant, sustaining a favorable business environment.

On the strength of the first-quarter performance, Omron raised its consolidated forecasts initially announced on May 13, 2026. The company now projects revenue of ¥880.0 billion (previously ¥820.0 billion, +14.6% over the prior fiscal year), operating profit of ¥80.0 billion (previously ¥62.0 billion, +41.7%), and net profit attributable to owners of the parent of ¥40.5 billion (previously ¥27.5 billion, +82.1%).

The upward revision is based on expectations that AI-driven demand will continue to fuel IAB growth, with semiconductor and secondary battery investments exceeding earlier estimates. The company also assumes a weak yen, with dollar and euro assumptions set at ¥155 and ¥180, respectively. In contrast, SSB is expected to see declining sales and profits amid fierce competition. Overall, however, Omron plans for a substantial profit increase versus the prior year.

Total assets at the end of the first quarter stood at ¥1,384.1 billion, up ¥20.8 billion from the end of the previous fiscal year. Cash and deposits rose sharply to ¥217.9 billion, leaving ample liquidity. Interest-bearing debt increased by ¥11.3 billion to ¥519.8 billion, primarily from new borrowings, but the equity ratio attributable to owners of the parent remained high at 60.1%.

Operating cash flow surged to ¥64.0 billion (versus ¥16.4 billion in the year-earlier period). Investing cash flow was negative ¥30.3 billion, including ¥17.2 billion for the acquisition of JMDC as a subsidiary. Financing cash flow was a positive ¥14.0 billion due to borrowings, resulting in a net increase in cash of ¥51.2 billion.

Omron plans to raise its annual dividend to ¥110 per share from ¥104 in the previous year. While no share buyback has been announced, the robust cash position suggests a supportive stance toward shareholder returns.

As part of its structural reforms, Omron has decided to transfer its Electronic Components Business (DMB) to The Carlyle Group. The transaction is scheduled for completion on October 1, 2026. The business has already been carved out into Aratas Corporation. Consequently, DMB is classified as a discontinued operation, and the company recorded a ¥3.4 billion loss from discontinued operations in the first quarter (versus a ¥0.15 billion loss a year earlier), reflecting impairment and other divestiture-related expenses.

Once the sale is finalized, Omron intends to concentrate management resources on growth areas such as IAB and HCB, accelerating its portfolio optimization strategy.